Multi-national and global pharmaceutical, medical device and medtech companies have always had to navigate a patchwork of compliance laws and regulations in the countries in which they operate, but as our global economy continues to evolve and grow, so do the regulatory considerations for companies in the life sciences sector. This webinar will focus on several new pieces of EU legislation that will have significant compliance implications for life sciences companies, including:
The planned amendmentsto the EU Product Liability Directive
EU law on class action lawsuits
The EU whistleblower directive
The planned EU human rights and environmental due diligence law
Our panellists will discuss how companies should best understand and manage implementation and enforcement of these laws at both the local and global level, by breaking down the compliance requirements along with areas of potential risk.